Top Markets
#1 Purr Purr +51.58%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 ApeX ApeX +22.50%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +21.92%
#5 Non-Playable Coin Non-Playable Coin +20.38%
#6 OriginTrail OriginTrail +19.93%
#7 龙虾 (Lobster) 龙虾 (Lobster) +19.21%
#8 Zora Zora +17.21%
#9 Pons Pons +16.45%
#10 Pendle Pendle +16.17%
Coin of the day
Purr Purr
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Pozycja w akcjach #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Cena akcji
$3.01
Ostatnia synchronizacja: 2024-04-12
Kapitalizacja rynkowa
$104.64M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Cyteir Therapeutics, Inc. (CYT)

Kategoria

Healthcare
Zyski dla Cyteir Therapeutics, Inc. (CYT)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Cyteir Therapeutics, Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Cyteir Therapeutics, Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH